PRVA Privia Health Group Inc

NASDAQ
$20.42

Privia Health Group Inc (PRVA) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus PRVA's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 2 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
2
11 transactions
Purchases
$0
0 shares
Sales
$12.2M
463,384 shares
Net activity
-$12.2M
purchases less sales

How much of that selling was preplanned? 100% planned / 0% discretionary

10b5-1 plan sales $12.2M 11 transactions · 463,384 shares
Discretionary sales $0 0 transactions · 0 shares

Largest single sale: $2.2M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Mountcastle David EVP & Chief Financial Officer Sell 10b5-1 21,275 $27.67 $588.7K 164,853 −11.4% of holding
Mountcastle David EVP & Chief Financial Officer Sell 10b5-1 600 $27.57 $16.5K 186,128 −0.3% of holding
Morris Matthew Shawn Director Sell 10b5-1 53,722 $27.24 $1.5M 68,188 −44.1% of holding
Morris Matthew Shawn Director Sell 10b5-1 59,037 $27.33 $1.6M 76,651 −43.5% of holding
Mountcastle David EVP & Chief Financial Officer Sell 10b5-1 24,734 $27.50 $680.2K 186,728 −11.7% of holding
Morris Matthew Shawn 2 fills Director Sell 10b5-1 82,675 $26.70 $2.2M 113,692 −42.1% of holding
Morris Matthew Shawn Director Sell 10b5-1 52,823 $25.72 $1.4M 76,651 −40.8% of holding
Morris Matthew Shawn Director Sell 10b5-1 63,212 $25.33 $1.6M 76,651 −45.2% of holding
Morris Matthew Shawn Director Sell 10b5-1 88,110 $25.33 $2.2M 76,651 −53.5% of holding
Mountcastle David EVP & Chief Financial Officer Sell 10b5-1 17,196 $25.18 $433.0K 211,462 −7.5% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.